Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.83 |
| ▸ | SNCA | P37840 | 1/20 | 0.83 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA5A | P35218 | 3/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.48 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.48 |
| ▸ | FLT3 | P36888 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.44 |
| ▸ | STIM1 | Q13586 | 1/20 | 0.43 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.43 |
| ▸ | MIF | P14174 | 1/20 | 0.42 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | STS | P08842 | 2/20 | 0.41 |
| ▸ | NME4 | O00746 | 1/20 | 0.41 |
| ▸ | GCDH | Q92947 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23405479 | 0.92 | MAPT (0.78) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL12682333 | 0.91 | SNCA (1.00) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL23405494 | 0.90 | MAPT (0.81) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL23405489 | 0.86 | MAPT (0.78) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL23405496 | 0.83 | MAPT (0.78) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL23405495 | 0.82 | MAPT (0.82) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL23405475 | 0.82 | MAPT (0.67) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL23405505 | 0.82 | MAPT (0.72) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL23405476 | 0.82 | MAPT (0.81) | MAPTSNCACA2CA1CA5A | |
| SCHEMBL23430997 | 0.80 | MAPT (0.77) | MAPTSNCACA2CA1CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12297178-B2 | Triazole derivative and use thereof | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2025-05-13 | — | — | US | claimed |
| US-20240166611-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2024-05-23 | — | — | US | claimed |
| US-20210163425-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2021-06-03 | — | — | US | claimed |
| US-12297178-B2 | Triazole derivative and use thereof | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2025-05-13 | — | — | US | disclosed |
| US-20240166611-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2024-05-23 | — | — | US | disclosed |
| US-20210163425-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2021-06-03 | — | — | US | disclosed |
| US-20210163425-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163425-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | FABP4, LIPC, GPR119 | MAPT 2951/4885SNCA 4775/4885CA2 3215/4885 |
| US-12297178-B2 | Triazole derivative and use thereof | FABP4, LIPC, GPR119 | MAPT 2945/4885SNCA 4771/4885CA2 3013/4885 |
| US-20240166611-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | FABP4, LIPC, GPR119 | MAPT 2945/4885SNCA 4771/4885CA2 3013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.